{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:23:08Z","timestamp":1778602988294,"version":"3.51.4"},"reference-count":35,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,9,29]]},"DOI":"10.1536\/ihj.21-044","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T22:08:53Z","timestamp":1631830133000},"page":"1026-1034","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology of Heart Valve Disease in Taiwan"],"prefix":"10.1536","volume":"62","author":[{"given":"Ching-Hu","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Medicine, Mackay Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jen","family":"Wang","sequence":"additional","affiliation":[{"name":"Edwards Lifesciences (Taiwan) Corp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ying","family":"Lee","sequence":"additional","affiliation":[{"name":"Edwards Lifesciences (Taiwan) Corp"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Helms AS, Bach DS. Heart valve disease. Prim Care 2013; 40: 91-108.","DOI":"10.1016\/j.pop.2012.11.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Clark MA, Arnold SV, Duhay FG, <i>et al<\/i>. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circ Cardiovasc Qual Outcomes 2012; 5: 697-704.","DOI":"10.1161\/CIRCOUTCOMES.112.966002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dvir D, Sagie A, Porat E, <i>et al<\/i>. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment. Catheter Cardiovasc Interv 2013; 81: 871-81.","DOI":"10.1002\/ccd.24623"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Benjamin EJ, Virani SS, Callaway CW, <i>et al<\/i>. Heart disease and stroke Statistics-2018 update: a report from the American Heart Association. Circulation 2018; 137: e67-e492.","DOI":"10.1161\/CIR.0000000000000573"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc 2010; 85: 483-500.","DOI":"10.4065\/mcp.2009.0706"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-11.","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. d&apos;Arcy JL, Coffey S, Loudon MA, <i>et al<\/i>. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE population cohort study. Eur Heart J 2016; 37: 3515-22.","DOI":"10.1093\/eurheartj\/ehw229"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang YT, Tao J, Maimaiti A, <i>et al<\/i>. Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China. PLoS One 2017; 12: e0174490.","DOI":"10.1371\/journal.pone.0174490"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007; 357: 439-41.","DOI":"10.1056\/NEJMp078039"},{"key":"10","unstructured":"10. Liu FZ, Xue YM, Liao HT, <i>et al<\/i>. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis 2014; 6: 1724-30."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ray S. Changing epidemiology and natural history of valvular heart disease. Clin Med (Lond) 2010; 10: 168-71.","DOI":"10.7861\/clinmedicine.10-2-168"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nishimura RA, Otto CM, Bonow RO, <i>et al<\/i>. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg 2014; 148: e1-e132.","DOI":"10.1161\/CIR.0000000000000031"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Baumgartner H, Falk V, Bax JJ, <i>et al<\/i>. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739-91.","DOI":"10.1093\/eurheartj\/ehx470"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nishimura RA, Otto CM, Bonow RO, <i>et al<\/i>. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation 2017; 135: e1159-95.","DOI":"10.1161\/CIR.0000000000000503"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol 2014; 30: 962-70.","DOI":"10.1016\/j.cjca.2014.03.022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart 2016; 102: 75-85.","DOI":"10.1136\/heartjnl-2014-307020"},{"key":"17","unstructured":"17. Affairs MoI. Abridged life table of Republic of China. Available at: https:\/\/wwwmoigovtw\/files\/site_node_file\/8610\/Abridged%20life%20table%20in%20Republic%20of%20China%20Area,%202018PDF. Accessed December 16, 2020."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hsieh CY, Su CC, Shao SC, <i>et al<\/i>. Taiwan&apos;s National health insurance research database: past and future. Clin Epidemiol 2019; 11: 349-58.","DOI":"10.2147\/CLEP.S196293"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lin LY, Warren-Gash C, Smeeth L, Chen PC. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health 2018; 40: e2018062.","DOI":"10.4178\/epih.e2018062"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gau SS, Chung CH, Gau CS. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in Taiwan. J Clin Psychopharmacol 2008; 28: 271-8.","DOI":"10.1097\/JCP.0b013e3181723713"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chung CH. EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: a cohort study in Taiwan. Oncol Lett 2019; 18: 6090-100.","DOI":"10.3892\/ol.2019.10942"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yeh MJ, Chang HH. National health insurance in Taiwan. Health Aff (Millwood) 2015; 34: 1067.","DOI":"10.1377\/hlthaff.2015.0447"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okamoto Y, Yamamoto K, Yoshii S. Early and late outcomes of aortic valve replacement using bioprosthetic versus mechanical valve in elderly patients: a propensity analysis. J Card Surg 2016; 31: 195-202.","DOI":"10.1111\/jocs.12719"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Head SJ, \u00c7elik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J 2017; 38: 2183-91.","DOI":"10.1093\/eurheartj\/ehx141"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kim DH, Kang DH. Early surgery in valvular heart disease. Korean Circ J 2018; 48: 964-73.","DOI":"10.4070\/kcj.2018.0308"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Nishimura RA, Otto CM, Bonow RO, <i>et al<\/i>. 2014 AHA\/ACC Guideline for the Management of Patients With valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation 2014; 129: e521-643.","DOI":"10.1161\/CIR.0000000000000031"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nishimura RA, Otto CM, Bonow RO, <i>et al<\/i>. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2017; 70: 252-89.","DOI":"10.1016\/j.jacc.2017.03.011"},{"key":"29","unstructured":"29. Baumgartner H, Falk V, Bax JJ, <i>et al<\/i>. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Rev Esp Cardiol (Engl Ed) 2018; 71: 110."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. De Sciscio P, Brubert J, De Sciscio M, Serrani M, Stasiak J, Moggridge GD. Quantifying the shift toward transcatheter aortic valve replacement in low-risk patients: a meta-analysis. Circ Cardiovasc Qual Outcomes 2017; 10.","DOI":"10.1161\/CIRCOUTCOMES.116.003287"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Iung B, Baron G, Butchart EG, <i>et al<\/i>. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J 2003; 24: 1231-43.","DOI":"10.1016\/S0195-668X(03)00201-X"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011; 8: 162-72.","DOI":"10.1038\/nrcardio.2010.202"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Singh JP, Evans JC, Levy D, <i>et al<\/i>. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham heart study). Am J Cardiol 1999; 83: 897-902.","DOI":"10.1016\/S0002-9149(98)01064-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Iung B, Baron G, Tornos P, Gohlke-B\u00e4rwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol 2007; 32: 609-61.","DOI":"10.1016\/j.cpcardiol.2007.07.002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Rubin J, Aggarwal SR, Swett KR, <i>et al<\/i>. Burden of valvular heart diseases in Hispanic\/latino individuals in the United States: the echocardiographic study of latinos. Mayo Clin Proc 2019; 94: 1488-98.","DOI":"10.1016\/j.mayocp.2018.12.035"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/5\/62_21-044\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T12:28:16Z","timestamp":1673267296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/5\/62_21-044\/_article"}},"subtitle":["A Population-Based Cohort Study"],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-044","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"article-number":"21-044"}}